GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (XTAE:OPK) » Definitions » Cyclically Adjusted Price-to-FCF

OPKO Health (XTAE:OPK) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is OPKO Health Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


OPKO Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted Price-to-FCF Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OPKO Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OPKO Health's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted Price-to-FCF falls into.



OPKO Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

OPKO Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, OPKO Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.209/131.7762*131.7762
=-0.209

Current CPI (Mar. 2024) = 131.7762.

OPKO Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.210 100.560 -0.275
201409 -0.195 100.428 -0.256
201412 -0.219 99.070 -0.291
201503 1.973 99.621 2.610
201506 -0.281 100.684 -0.368
201509 -0.282 100.392 -0.370
201512 -0.107 99.792 -0.141
201603 -0.129 100.470 -0.169
201606 0.264 101.688 0.342
201609 -0.275 101.861 -0.356
201612 0.184 101.863 0.238
201703 -0.288 102.862 -0.369
201706 -0.196 103.349 -0.250
201709 -0.349 104.136 -0.442
201712 -0.082 104.011 -0.104
201803 -0.274 105.290 -0.343
201806 -0.158 106.317 -0.196
201809 -0.224 106.507 -0.277
201812 -0.243 105.998 -0.302
201903 -0.327 107.251 -0.402
201906 -0.360 108.070 -0.439
201909 -0.166 108.329 -0.202
201912 -0.296 108.420 -0.360
202003 -0.283 108.902 -0.342
202006 -0.150 108.767 -0.182
202009 0.307 109.815 0.368
202012 0.158 109.897 0.189
202103 0.097 111.754 0.114
202106 -0.139 114.631 -0.160
202109 0.148 115.734 0.169
202112 -0.070 117.630 -0.078
202203 -0.141 121.301 -0.153
202206 -0.087 125.017 -0.092
202209 -0.196 125.227 -0.206
202212 -0.187 125.222 -0.197
202303 -0.126 127.348 -0.130
202306 -0.031 128.729 -0.032
202309 0.142 129.860 0.144
202312 -0.203 129.419 -0.207
202403 -0.209 131.776 -0.209

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OPKO Health  (XTAE:OPK) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


OPKO Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (XTAE:OPK) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.